Does ROSIGLITAZONE Cause Pericardial effusion? 115 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 115 reports of Pericardial effusion have been filed in association with ROSIGLITAZONE. This represents 0.3% of all adverse event reports for ROSIGLITAZONE.
115
Reports of Pericardial effusion with ROSIGLITAZONE
0.3%
of all ROSIGLITAZONE reports
14
Deaths
105
Hospitalizations
How Dangerous Is Pericardial effusion From ROSIGLITAZONE?
Of the 115 reports, 14 (12.2%) resulted in death, 105 (91.3%) required hospitalization.
Is Pericardial effusion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROSIGLITAZONE. However, 115 reports have been filed with the FAERS database.
What Other Side Effects Does ROSIGLITAZONE Cause?
Myocardial infarction (17,018)
Cardiac failure congestive (15,085)
Cerebrovascular accident (7,899)
Coronary artery disease (4,982)
Acute myocardial infarction (2,437)
Cardiac disorder (1,732)
Coronary arterial stent insertion (1,698)
Coronary artery bypass (1,181)
Chest pain (990)
Myocardial ischaemia (970)
What Other Drugs Cause Pericardial effusion?
TREPROSTINIL (584)
IBRUTINIB (467)
CYCLOPHOSPHAMIDE (458)
NIVOLUMAB (454)
METHOTREXATE (412)
MACITENTAN (407)
DASATINIB (388)
ADALIMUMAB (374)
AMBRISENTAN (371)
PEMBROLIZUMAB (362)
Which ROSIGLITAZONE Alternatives Have Lower Pericardial effusion Risk?
ROSIGLITAZONE vs ROSUVASTATIN
ROSIGLITAZONE vs ROSUVASTATIN\ROSUVASTATIN
ROSIGLITAZONE vs ROTIGOTINE
ROSIGLITAZONE vs ROXADUSTAT
ROSIGLITAZONE vs ROXICODONE